Li, Q.; Demir, S.; Del Río-Álvarez, Á.; Maxwell, R.; Wagner, A.; Carrillo-Reixach, J.; Armengol, C.; Vokuhl, C.; Häberle, B.; von Schweinitz, D.;
et al. Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers 2022, 14, 4196.
https://doi.org/10.3390/cancers14174196
AMA Style
Li Q, Demir S, Del Río-Álvarez Á, Maxwell R, Wagner A, Carrillo-Reixach J, Armengol C, Vokuhl C, Häberle B, von Schweinitz D,
et al. Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers. 2022; 14(17):4196.
https://doi.org/10.3390/cancers14174196
Chicago/Turabian Style
Li, Qian, Salih Demir, Álvaro Del Río-Álvarez, Rebecca Maxwell, Alexandra Wagner, Juan Carrillo-Reixach, Carolina Armengol, Christian Vokuhl, Beate Häberle, Dietrich von Schweinitz,
and et al. 2022. "Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma" Cancers 14, no. 17: 4196.
https://doi.org/10.3390/cancers14174196
APA Style
Li, Q., Demir, S., Del Río-Álvarez, Á., Maxwell, R., Wagner, A., Carrillo-Reixach, J., Armengol, C., Vokuhl, C., Häberle, B., von Schweinitz, D., Schmid, I., Cairo, S., & Kappler, R.
(2022). Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers, 14(17), 4196.
https://doi.org/10.3390/cancers14174196